logo
Despite 5L govt cover, heart patient relies on charity for op

Despite 5L govt cover, heart patient relies on charity for op

Time of India03-05-2025

Mumbai: Riddled for a decade with a heart ailment described by doctors as a "poor man's burden", 24-year-old Rinki Sudhar finally got treated at civic-run
Sion Hospital
last week. The
rheumatic heart disease
(RHD) she contracted at age 13 had constricted her mitral heart valve, leading to persistent cough, sleeplessness and breathlessness.
Multiple misdiagnoses meant the UP resident had visited multiple hospitals across India, but the disease stayed true to its moniker. Despite her family being insured for Rs 5 lakh per year under the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (PMJAY), she needed charity for the procedure. Doctors led by cardiologist Dr Milind Phadke at Sion Hospital arranged for Rs 50,000 through a donor for a balloon mitral valvuloplasty (BMV).
You Can Also Check:
Mumbai AQI
|
Weather in Mumbai
|
Bank Holidays in Mumbai
|
Public Holidays in Mumbai
Public hospitals don't charge surgeon's fees or levy room charges, but patients require to pay for medical devices or instruments. This is where public insurance schemes like the state's Mahatma Phule Jan Arogya Yojana (MPJAY) or PMJAY come in. But Rinki was only eligible for the latter as she was not a Maharashtra resident.
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Free P2,000 GCash eGift
UnionBank Credit Card
Apply Now
Undo
Insurance Gaps
Sudhar's case highlights the gaps and inadequacies in India's public health insurance schemes. According to PMJAY documents, the reimbursement for BMV was Rs 27,500 in 2020 and increased to Rs 35,700 recently. However, Sion Hospital's latest internal records show reimbursement of up to Rs 27,500 under PMJAY; in practice, only Rs 20,000 is allowed.
The cost of the balloon catheter alone is Rs 50,000, but even the state scheme (MPJAY) didn't cover BMV completely until last year. "When Rinki's case came up, there was a kind donor who wished to fund complete treatment of a cardiac patient. All the costs were taken care of by them, and that saved her life," said Dr Phadke, who operated on Sudhar.
Poor Man's Burden
RHD is rooted in deprivation. It begins with a sore throat caused by an untreated streptococcus infection, which can trigger an immune response that damages the mitral heart valve over time.
Rinki's father Ram (57), a watchman at an Andheri housing society, said her condition was often misdiagnosed. "Some doctors told us she had TB, some gave her vitamin injections," said Ram, who hails from Amethi. Dr Pratap Nathani, head of the cardiology department at Sion Hospital, said, "Factors such as malnutrition, lack of early access to diagnosis and treatment contribute to RHD."
Although Rinki's condition became unbearable in the past six months, it was only last month that RHD was diagnosed through a 2D-echo scan at a hospital in Sultanpur. She was referred to a govt hospital in Kanpur. "There was a long wait list, so we were sent to Lucknow," said Ram. In the meantime, they got their Ayushman Bharat card, and rushed to Mumbai. A resident at the building he works at helped him with Sion Hospital.
Recurring Troubles
State-run JJ Hospital, Byculla, treated around 200 RHD patients last year. "Most were covered by MJPJAY," said a cardiologist, adding problems arose when a patient was from outside Maharashtra. "We struggle with PMJAY as we need to approach trusts and donors to cover costs." A cardiologist from Parel's civic-run KEM Hospital said they used cross-subsidisation. "For some patients, the insurance amount is more than enough, so we use the excess amount to fund the deficit in another patient's coverage."
A former CEO of National Health Authority, which implements PMJAY, said, "There is a well-established mechanism in NHA to fix the rates. NHA doesn't fix the rates unilaterally and state considerations are taken into account.''
MJPJAY CEO Aannasaheb Chavan said there were similar issues at state-level, but most have been resolved since the state and union schemes merged. "We are also in the process of reviewing rates in the combined scheme,'" he said. A committee, headed by public health department head Amgothu Sri Ranga Naik, has been set up.
Dr Soumitra Ghosh from TISS's Centre for Health Policy, Planning and Management said, "It's common for patients under PMJAY to incur hefty out-of-pocket expenditures.'' Although PMJAY budget increased over the years, its beneficiaries too increased. "But the rates for specific procedures didn't increase accordingly," he said, adding, "Some health economists estimate that if the scheme truly offers coverage of Rs 5 lakh per family as promised, then the entire health budget would need to be allocated to it in order to keep it functional without any issues. Since that is not the amount of money currently allocated, the actual coverage cost is much lower than what is promised."
Not the End
Rinki, who is still in hospital, said she can now sleep without coughing. "I will look for a job, hopefully as a worker in a school," she said. But her cycle of deprivation has far from ended: The new valve will hold for at least 10 years before the narrowing restarts.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

WHO DG holds talks with PM's Secy on partnership at Global Traditional Medicine Centre
WHO DG holds talks with PM's Secy on partnership at Global Traditional Medicine Centre

Time of India

timean hour ago

  • Time of India

WHO DG holds talks with PM's Secy on partnership at Global Traditional Medicine Centre

Geneva: Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus on Thursday (local time) held talks with PK Mishra , Principal Secretary to Prime Minister where they discussed their partnership on the WHO Global Traditional Medicine Centre , outposted in Jamnagar . Ghebreyesus thanked Mishra for India's leadership on the Pandemic Accord adoption, and support of increased assessed contributions to WHO's work to advance health for all. "Had good meeting with P.K. Mishra, Principal Secretary to PMO India, on the many areas of close collaboration between WHO and India. We discussed our partnership on the WHO Global Traditional Medicine Centre, outposted in Jamnagar, which will help the world benefit from the potential of traditional medicine and complement modern approaches to health. I thanked Dr Mishra for India's leadership on the Pandemic Accord adoption, and support of increased assessed contributions to WHO's work to advance Health for All. I also commended India for its investment in health care infrastructure, the " Ayushman Bharat " scheme to expand universal health coverage, and in digital health." Mishra also held talks with Hara Hiroaki, Vice-Minister for Policy Coordination of Japan, on margins of Global Platform for Disaster Risk Reduction 2025. In a post on X, the Indian Permanent Mission at Geneva stated, "Fruitful discussions between Principal Secretary to PM Dr. P.K Mishra and Mr. Hara Hiroaki, Vice-Minister for Policy Coordination of Japan, on margins of GPDRR 2025. Explored enhanced India-Japan collaboration on disaster resilience and exchanging expertise in risk reduction strategies." Mishra also held talks on disaster preparedness with Major General Ariunbuyan Gombojav, Chief of National Emergency Management Agency of Mongolia, on the sidelines of GPDRR 2025. "Principal Secretary to PM Dr. P.K Mishra meets with Major General Ariunbuyan Gombojav, Chief of National Emergency Management Agency of Mongolia, on the sidelines of GPDRR 2025. Valuable exchange on disaster preparedness strategies and exploring opportunities for India-Mongolia cooperation in DRR." Mishra also held talks with Head of UNDRR Kamal Kishore on strengthening India's disaster risk reduction partnerships and advancing global resilience frameworks. Meanwhile, BIMSTEC countries convened at the High-Level UNDRR-BIMSTEC event on the margins of GPDRR 2025 in Geneva. India's head of delegation to GPDRR, Principal Secretary to PM PK Mishra, highlighted the role of the BIMSTEC Centre for Disaster Management, as announced by PM Narendra Modi at the 6th BIMSTEC Summit, to accelerate the region's implementation of the Sendai Framework.

Telangana Cabinet okays pending DAs for govt staff
Telangana Cabinet okays pending DAs for govt staff

United News of India

time6 hours ago

  • United News of India

Telangana Cabinet okays pending DAs for govt staff

Hyderabad, May 6 (UNI) In the backdrop of employee unions threatening agitation over long pending demands, the Telangana Cabinet has approved the release of two pending Dearness Allowances (DAs) to the staff and also sanctioned Rs 700 crore to clear their pending bills. Briefing the media after a marathon cabinet meeting chaired by Chief Minister a Revanth Reddy held here on Thursday night, Deputy Chief Minister Bhatti Vikramarka said that a part of the two DAs will be implemented immediately, and another six months. Bhatti, who heads the cabinet sub-committee on employees' grievances, gave a detailed presentation and said it was decided that the pending bills of employees amounting to ₹700 crore per month should be cleared without delay. About the health insurance scheme for employees, he said a trust would be set up under the leadership of the chief secretary and officials would be members of the trust. Under the scheme, each employee will contribute ₹500 per month, and the government will contribute an equal amount, the Deputy CM said. He said the government accepted the employee unions' demand for a 12.5 per cent quota in the secretariat. The government was also inclined to form a medical invalidation committee to assess cases of medical retirement, he said. The cabinet decided not to re-employ retired employees, he said. Referring to grading of panchayat staff, Bhatti said employees working in village panchayats would be graded according to the panchayats' classification. The Departmental Promotion Committee (DPC) will be set up for processing employees' promotions, said the minister. Officers and employees who were transferred during the election period would be sent back to their original positions, he said. The government agreed to establish a director of nursing, he said, adding the Cabinet decided to increase Rs 2 lakh towards retirement benefits for Anganwadi workers. The pending bills related to government officials' rental vehicles would be cleared, and the vehicle limits will be revised upwards, he added. UNI KNR PRS

Universal Artificial Blood For All Types In Clinical Trials, Could Save Millions
Universal Artificial Blood For All Types In Clinical Trials, Could Save Millions

NDTV

time7 hours ago

  • NDTV

Universal Artificial Blood For All Types In Clinical Trials, Could Save Millions

In a medical breakthrough that could save millions of lives, Japanese researchers have started clinical trials to explore the effectiveness and safety of universal artificial blood. Led by Professor Hiromi Sakai at Nara Medical University, the artificial blood, usable for all blood types, could have a shelf life of up to two years. If successful, it could transform the emergency medicare system across the globe. Their approach involves extracting haemoglobin, the oxygen-carrying molecule in red blood cells, from expired donor blood. It is then encased in a protective shell to create stable, virus-free artificial red blood cells, according to a report in Newsweek. Unlike donated blood, these artificial cells have no blood type, eliminating the need for compatibility testing and making them invaluable in emergencies. Notably, donated blood has a shelf life of just 42 days, and even then, there is not enough of it, and requires compatibility amongst different blood groups. For the trial, the researchers administered 100 to 400 millilitres of the artificial blood to 16 healthy adult volunteers in March. If the test safety and efficacy are achieved, the researchers are hoping for practical use by 2030, making Japan the first country in the world to deploy artificial blood for real-world medical care. "The need for artificial blood cells is significant as there is currently no safe substitute for red cells," said Professor Sakai. Social media reacts Reacting to the start of the clinical trials, social media users marvelled at the potential implications with some claiming it was a Nobel Prize-winning endeavour, if it was a success. "If true, and not inordinately expensive, this is going to be completely transformational," said one user, while another added: "If it is safe, this is worth a Nobel Prize." A third commented: "Japanese scientists are really doing the most between this, regrowing teeth, and the shots that make cats live longer. Really hope this stuff makes it worldwide." Notably, the US has been developing ErythroMer (made from 'recycled' haemoglobin) for the past few years, and has already started pre-clinical testing. Last year, the Defense Advanced Research Projects Agency (DARPA) announced a Rs 394 crore ($46 million) grant to a University of Maryland-led consortium to develop a shelf-stable, field-deployable whole blood substitute with ErythroMer as its core.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store